Zheng Xing Xing Ye Ri Bao·2025-11-05 08:42Market Overview - The biopharmaceutical sector experienced a decline of 0.96% on November 5, with He Yuan Bio leading the drop [1] - The Shanghai Composite Index closed at 3969.25, up 0.23%, while the Shenzhen Component Index closed at 13223.56, up 0.37% [1] Stock Performance - Notable gainers in the biopharmaceutical sector included: - Jinke (688670) with a closing price of 18.09, up 3.37% [1] - Kanghua Bio (300841) at 79.20, up 1.93% [1] - Wuxi Jinghai (920547) at 27.87, up 1.46% [1] - Significant decliners included: - Buyuan Bio (688765) at 112.00, down 12.55% [2] - SanSheng Guojian (688336) at 70.10, down 8.47% [2] - Rongchang Bio (688331) at 92.00, down 4.90% [2] Trading Volume and Capital Flow - The biopharmaceutical sector saw a net outflow of 668 million yuan from institutional investors, while retail investors contributed a net inflow of 380 million yuan [2] - The trading volume for key stocks included: - Kanghua Bio with a trading volume of 43,600 shares and a transaction value of 345 million yuan [1] - Buyuan Bio with a trading volume of 185,800 shares and a transaction value of 2.206 billion yuan [2] Capital Inflow Analysis - Major stocks with net inflows from institutional investors included: - Kanghua Bio with a net inflow of 40.48 million yuan, accounting for 11.72% of its trading volume [3] - Hualan Bio with a net inflow of 31.05 million yuan, accounting for 4.66% [3] - Conversely, stocks like Jinke experienced a net outflow of 13.56 million yuan from retail investors, representing 17.39% of its trading volume [3]